Recovery from hepatitis A after Korean medicine-based treatment : a case report
| Autor: | Chang-Gue Son, Gayoung Lee, Nam-Hun Lee, Jung-Hyo Cho, Chan-ran Park |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Abdominal pain medicine.medical_treatment 0211 other engineering and technologies Case Report 02 engineering and technology Moxibustion Gastroenterology 03 medical and health sciences Liver disease 0302 clinical medicine Internal medicine 021105 building & construction medicine Acupuncture Blood test Adverse effect lcsh:Miscellaneous systems and treatments medicine.diagnostic_test business.industry Hepatitis A Korean medicine lcsh:RZ409.7-999 medicine.disease 030205 complementary & alternative medicine Complementary and alternative medicine Vomiting medicine.symptom Chungganplus business |
| Zdroj: | Integrative Medicine Research Integrative Medicine Research, Vol 8, Iss 4, Pp 257-260 (2019) |
| ISSN: | 2213-4239 2213-4220 |
| Popis: | Background: Many studies reported that Korean medicine (KM) is effective for treating liver disease, including hepatitis A. However, KM, specifically with herbal medicine (Chungganplus, CGP) has not been reported yet. We aimed to report a patient with hepatitis A who was treated with KM including CGP, acupuncture, and moxibustion for 12 days. Methods: A 39-year-old man with hepatitis A who was hospitalized for 12 days after being admitted to our hospital with abdominal pain, diarrhea and vomiting. We prescribed CGP three times a day, with acupuncture performed twice daily and moxibustion at conception vessel (CV)-12 once a day. Follow-up blood tests have been done 4 times during the admission in order to access the effect of the treatment. Results: In 12 days the symptoms had disappeared and the blood test results improved steadily. His AST level have declined from 1,189 IU/L to 44 IU/L, ALT from 2,423 IU/L to 127 IU/L, r-GTP from 1,347 IU/L to 339 IU/L, ALP from 384 IU/L to 205 IU/L, and total bilirubin from 3.6 mg/dL to 0.89 mg/dL. Conlcusion: This case suggests that KM-based treatment using CGP may be effective for hepatitis A with no adverse effect. Further research and clinical trial on CGP would be needed to make the basis more valid. Keywords: Hepatitis A, Korean medicine, Chungganplus |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|